Abeona Therapeutics Inc [ABEO] stock prices are up 5.21% to $6.26 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ABEO shares have gain 7.38% over the last week, with a monthly amount glided 1.62%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Oppenheimer started tracking the stock with Outperform rating on March 05, 2025, and set its price target to $16. On July 03, 2024, H.C. Wainwright initiated with a Buy rating and assigned a price target of $15 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $21 on May 30, 2024. Cantor Fitzgerald upgraded its rating to a Overweight but $4 remained the price target by the analyst firm on November 11, 2020. B. Riley FBR started tracking with a Buy rating for this stock on September 18, 2020, and assigned it a price target of $5. In a note dated February 10, 2020, SVB Leerink initiated an Outperform rating and provided a target price of $6 on this stock.
The stock price of Abeona Therapeutics Inc [ABEO] has been fluctuating between $3.93 and $7.32 over the past year. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. Abeona Therapeutics Inc [NASDAQ: ABEO] shares were valued at $6.26 at the most recent close of the market. An investor can expect a potential return of 187.54% based on the average ABEO price forecast.
Analyzing the ABEO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.44, Equity is -0.86 and Total Capital is -0.86. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.06 points at the first support level, and at 5.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.38, and for the 2nd resistance point, it is at 6.50.
Ratios To Look Out For
It’s worth pointing out that Abeona Therapeutics Inc [NASDAQ:ABEO]’s Current Ratio is 4.90. Also, the Quick Ratio is 4.90, while the Cash Ratio stands at 0.89.
Transactions by insiders
Recent insider trading involved Silverstein Christine Berni, Director, that happened on Jul 09 ’25 when 13093.0 shares were sold. Chief Executive Officer, Seshadri Vishwas completed a deal on Jul 09 ’25 to sell 69420.0 shares. Meanwhile, Chief Financial Officer Vazzano Joseph Walter sold 25411.0 shares on Jul 09 ’25.
